terazosin has been researched along with bmy 7378 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bock, MG; Broten, TP; Chang, RS; DiSalvo, J; Forray, C; Patane, MA; Ransom, RW; Scott, AL | 1 |
| Pedretti, A; Testa, B; Villa, L; Vistoli, G | 1 |
| Ballard, S; Blagg, J; Fox, D; Kenny, B | 1 |
| Guarneri, L; Leonardi, A; Testa, R; Velasco, C | 1 |
1 review(s) available for terazosin and bmy 7378
| Article | Year |
|---|---|
Pharmacological options in the treatment of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship | 1997 |
3 other study(ies) available for terazosin and bmy 7378
| Article | Year |
|---|---|
4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Humans; Male; Organ Specificity; Prazosin; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Spinal Cord; Structure-Activity Relationship | 1998 |
Range and sensitivity as descriptors of molecular property spaces in dynamic QSAR analyses.
Topics: Chemical Phenomena; Chemistry, Physical; Ligands; Models, Molecular; Molecular Conformation; Monte Carlo Method; Quantitative Structure-Activity Relationship; Receptors, Adrenergic, alpha-1; Solvents | 2005 |
Effects of intravenous and infravesical administration of suramin, terazosin and BMY 7378 on bladder instability in conscious rats with bladder outlet obstruction.
Topics: Administration, Intravesical; Adrenergic alpha-Antagonists; Animals; Female; Infusions, Intravenous; Ligation; Piperazines; Prazosin; Purinergic Antagonists; Rats; Rats, Sprague-Dawley; Suramin; Urethral Obstruction; Urinary Bladder Neck Obstruction; Urination; Urination Disorders; Urodynamics | 2003 |